These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2076713)

  • 41. Clinical review of perindopril in the treatment of hypertension.
    Lerebours G; Antony I
    Can J Cardiol; 1994 Nov; 10 Suppl D():3D-7D. PubMed ID: 7954037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term acceptability of perindopril: European multicenter trial on 856 patients.
    Degaute JP; Leeman M; Desche P
    Am J Med; 1992 Apr; 92(4B):84S-90S. PubMed ID: 1580287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?
    Plouin PF; Battaglia C; Alhenc-Gélas F; Corvol P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):356-62. PubMed ID: 2059395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
    Harrap SB; Van der Merwe WM; Griffin SA; Macpherson F; Lever AF
    Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive and humoral effects of nifedipine in essential hypertension uncontrolled by hydrochlorothiazide alone.
    Opsahl JA; Halstenson CE; Abraham PA
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):828-33. PubMed ID: 2686710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension.
    Mehta J; Lopez LM; Thorman AD
    Am J Cardiol; 1988 Apr; 61(10):803-6. PubMed ID: 2833090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients.
    Lees KR; Reid JL
    Eur J Clin Pharmacol; 1987; 31(5):519-24. PubMed ID: 3030762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term and long-term cardiovascular actions of different doses of perindopril in the rabbit.
    Fennessy PA; Godwin S; Head GA; Campbell JH; Campbell GR
    Pharmacol Res; 1996; 34(3-4):135-41. PubMed ID: 9051705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of blood pressure control with once daily administration of enalapril and perindopril.
    Anderson A; Morgan O; Morgan T
    Am J Hypertens; 1994 Apr; 7(4 Pt 1):371-3. PubMed ID: 8031555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects.
    Abdel-Haq B; Magagna A; Favilla S; Salvetti A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S33-6. PubMed ID: 1725198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P; Overlack A; Agnes E; Desche P
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group.
    Meyer BH; Pauly NC
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S77-80. PubMed ID: 7527107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
    Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P
    Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.
    Brown NJ; Kumar S; Painter CA; Vaughan DE
    Hypertension; 2002 Dec; 40(6):859-65. PubMed ID: 12468570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R; Castellote E; Ocón J; Wagner B
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Todd PA; Fitton A
    Drugs; 1991 Jul; 42(1):90-114. PubMed ID: 1718688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients.
    Nilsen OG; Sellevold OF; Romfo OS; Smedsrud A; Grynne B; Williams PE; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.